Czernin Johannes
Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic, UCLA School of Medicine, Los Angeles, CA 90095, USA.
Mol Imaging Biol. 2002 Jan;4(1):35-45. doi: 10.1016/s1095-0397(01)00069-3.
The current review addresses the role of whole-body PET imaging for diagnosing, staging, and re-staging of breast cancer, as well as its role for monitoring effects of treatment on breast cancer. The strengths and limitations of the conventional imaging modalities and those of PET are discussed. New solutions for relatively inexpensive PET screening of patients at risk for breast cancer are proposed. Clinical indications for PET in breast cancer are specified.
本综述探讨了全身PET成像在乳腺癌诊断、分期及再分期中的作用，以及其在监测乳腺癌治疗效果方面的作用。讨论了传统成像方式和PET的优势与局限性。提出了针对乳腺癌高危患者进行相对廉价PET筛查的新方案。明确了PET在乳腺癌中的临床应用指征。
